Business, energy, technology, markets and global industry news from Business News Today

HBM Holdings Limited

PharmaDeviceNews HBM Holdings Limited
Representative biotech patent litigation image showing antibody discovery research, laboratory documents and legal symbols.
Pharma & Biotech

Could Harbour BioMed’s legal win reshape the economics of antibody drug discovery?

Read how Harbour BioMed’s Amgen patent win could reshape antibody discovery licensing, biologics IP and biotech investor sentiment.

Read More
Representative image: Harbour BioMed’s FDA-cleared HBM7004 IND highlights the growing race to develop B7-H4xCD3 bispecific antibodies for advanced solid tumors, as biotech firms test whether next-generation immunotherapies can improve cancer treatment options beyond conventional approaches.
Pharma & Biotech

HBM7004 FDA clearance gives Harbour BioMed a fresh solid tumor immunotherapy test

Solid tumor T-cell engagers still face safety limits. Harbour BioMed’s HBM7004 now tests whether B7-H4 can widen that window.

Read More